<bill session="115" type="h" number="6575" updated="2023-01-11T13:41:55Z">
  <state datetime="2018-07-26">REFERRED</state>
  <status>
    <introduced datetime="2018-07-26"/>
  </status>
  <introduced datetime="2018-07-26"/>
  <titles>
    <title type="display">Medicare Prescription Drug Savings and Choice Act of 2018</title>
    <title type="official" as="introduced">To amend part D of title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program.</title>
    <title type="short" as="introduced">Medicare Prescription Drug Savings and Choice Act of 2018</title>
  </titles>
  <sponsor bioguide_id="S001145"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-07-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-07-26" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-07-26">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-07-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-08-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="h" number="1775" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Government studies and investigations"/>
    <term name="Health care coverage and access"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-05T18:23:39Z" status="Introduced in House">Medicare Prescription Drug Savings and Choice Act of 2018

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit.&#160; In doing so, the CMS must: (1) negotiate prices&#160;with drug manufacturers;&#160;(2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.</summary>
</bill>
